Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Circulating Biomarker
3.3. Snippet by Application
3.4. Snippet by Technology
3.5. Snippet by End User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Cancer
4.1.1.2. Rise in Customized Laser Surgery Based on Eye Biomechanics
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. Standardization and Regulatory Challenges
4.1.2.2. High Cost of Treatment Procedures
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Markets
4.1.3.2. XX
4.1.4. Impact Analysis
5. Strategic Insights and Industry Outlook
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with largest selling Brand
5.1.3. Market leaders with established Product
5.2. CXO Perspectives
5.3. Latest Developments and Breakthroughs
5.4. Case Studies/Ongoing Research
5.5. Regulatory and Reimbursement Landscape
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. Porter’s Five Force Analysis
5.7. Pipeline Analysis
5.8. Supply Chain Analysis
5.9. Patent Analysis
5.10. SWOT Analysis
5.11. Unmet Needs and Gaps
5.12. Recommended Strategies for Market Entry and Expansion
5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.14. Pricing Analysis and Price Dynamics
5.15. Key Opinion Leaders
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Kits & Reagents*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Instruments
6.4. Services
7. By Circulating Biomarker
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
7.1.2. Market Attractiveness Index, By Circulating Biomarker
7.2. Circulating Tumor Cells*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Circulating Tumor DNA (ctDNA)
7.4. Cell-free DNA (cfDNA)
7.5. Extracellular Vesicles
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cancer Applications*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Non-Cancer Applications
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Multi-gene-parallel Analysis (NGS)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Single Gene Analysis (PCR Microarrays)
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Physician Laboratories*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Research Centers
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. U.S.
11.2.8.2. Canada
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. U.K.
11.3.8.3. France
11.3.8.4. Spain
11.3.8.5. Italy
11.3.8.6. Rest of Europe
11.4. Latin America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Mexico
11.4.8.2. Brazil
11.4.8.3. Argentina
11.4.8.4. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. South Korea
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
Key Market Players
13.1. Exosome Sciences Inc*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
13.1.3. Financial Overview
13.1.3.1. Company Revenue’s
13.1.3.2. Geographical Revenue Shares
13.1.3.3. Revenue Forecasts
13.1.4. Key Developments
13.1.4.1. Mergers & Acquisitions
13.1.4.2. Key Product Development Activities
13.1.4.3. Regulatory Approvals etc.
13.1.5. SWOT Analysis
13.2. Illumina, Inc
13.3. Guardant Health
13.4. Thermo Fisher Scientific Inc
13.5. NeoGenomics Laboratories
13.6. Qiagen
13.7. BioChain Institute Inc
13.8. Sysmex Europe SE
13.9. Eurofins Genomics
13.10. Goffin Molecular Technologies
* Similar data will be provided for each market player.
Emerging Market Players
13.11. Exact Sciences*
13.11.1. Pipeline Products Description
13.11.2. Product Key Performance Indicators (KPIs)
13.11.3. Key Activities
13.11.4. Market Entry Timelines
13.11.5. Product Penetration Rate
13.11.6. Sales Estimation and Projections
13.12. Tempus
13.13. Dxcover Limited
* Similar data will be provided for each market player.
LIST NOT EXHAUSTIVE
12. Appendix
12.1 About Us and Services
12.2 Contact Us